USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BIOELECTROMED CORPORATION
Address:
849 MITTEN RD
STE 104
BURLINGAME, CA
Phone:
N/A
URL:
N/A
EIN:
943383868
DUNS:
64678464
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,012,977.00 4
SBIR Phase II $6,910,458.00 4

Award List:

Development of Bioelectric Field Imaging Instrumentation

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$176,217.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We have known for over a century, that human skin drives ionic current out of regions where the integrity of the epidermis has been breached (DuBois-Reymond, 1843,Ann.Phys.U.Chem.58:1) DuBois-Reymond used one of the earliest galvanometers to measure 1 uA… More

Development of Bioelectric Field Imaging Instrumentation

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$1,218,955.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): For over a century we have known that human skin drives ionic current out of wounded regions. DuBois- Reymond (1848) used one of the earliest galvanometers to measure 1 microampere leaving wounds in his skin. This has been confirmed using modern techniques… More

Development of an electrical diagnostic for melanoma

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$163,787.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): RPN Research has recently developed a new instrument called the Bioelectric Field Imager (BFI) that allows us to measure the surface potential of the skin without touching it. We have used the BFI to map the lateral electric field surrounding a skin wound in mice… More

DEVELOPMENT OF AN ELECTRICAL DIAGNOSTIC FOR MELANOMA

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$1,788,693.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): RPN Research has developed a new medical device, the Bioelectric Field Imager (BFI) which can measure the electric field in human skin non-invasively. The hand-held BFI scans a vibrating sensor over the skin without mak ing contact with it and plots the surface… More

Development of a nanosecond pulsed electric field system to treat skin cancer

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$200,016.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): BioElectroMed is developing a new medical device called the NANOTOUCH that will utilize nanosecond pulsed electric fields to eliminate both benign and malignant skin lesions. We have used the NANOTOUCH to treat thre e different malignant lesions in mice,… More

DEVELOPMENT OF A NANOSECOND PULSED ELECTRIC FIELD SYSTEM TO TREAT SKIN CANCER

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,695,820.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): BioElectroMed is developing a new medical device called the PulseCure System that utilizes nanosecond pulsed electric fields to eliminate both benign and malignant skin lesions. We have used the PulseCure to treat malig nant melanoma and basal cell carcinoma in… More

EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$472,957.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): BioElectroMed is developing a new medical device called the EndoPulse that will deliver nanosecond pulsed electric fields (nsPEF) to treat pancreatic carcinomas. We have extensive evidence supporting the efficacy of nsP EF in eliminating all three types of skin… More

EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$2,206,990.00
Agency:
HHS
Principal Investigator:
Richard L. Nuccitelli – 650-393-9507
Abstract:
DESCRIPTION (provided by applicant): BioElectroMed is developing a new medical device called the EndoPulse that works in conjunction with an echoendoscope to deliver nanosecond pulsed electric field therapy to treat pancreatic carcinoma as well as lesions in the kidney and liver. The EndoPulse … More